Sangamo Therapeutics

Sangamo Therapeutics, Inc. | Pioneering Genetic Cures

Sangamo uses a multi-platform approach to gene-based therapeutics with industry leading technologies in gene therapy, gene editing, cell therapy and gene ...

Sangamo Therapeutics, Inc. - LinkedIn

Sangamo Therapeutics, Inc. | 41505 followers on LinkedIn. We're committed to translating our ground-breaking science into genomic medicines that transform ...

Sangamo Therapeutics, Inc. (SGMO) - Yahoo Finance

Sangamo Therapeutics, Inc. (SGMO) · Previous Close 2.4400 · Open 2.5300 · Bid -- · Ask -- · Day's Range 2.1000 - 2.5400 · 52 Week Range 0.3000 - 3.1800 · Volume ...

Sangamo Therapeutics - Wikipedia

an American biotechnology company based in Brisbane, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases.

Sangamo Therapeutics, Inc. - BioSpace

Sangamo Therapeutics, Inc. ... Sangamo Therapeutics is a genomic medicine company building value with cutting-edge work across four distinct but complementary ...

Sangamo Therapeutics Inc (SGMO) Q3 2024 Earnings Call Highlights

Key regulatory milestones and financial updates position Sangamo Therapeutics Inc (SGMO) for potential growth despite funding challenges.

Sangamo Therapeutics Inc (SGMO) Stock Price & News - Google

Get the latest Sangamo Therapeutics Inc (SGMO) real-time quote, historical performance, charts, and other financial information to help you make more ...

Sangamo Therapeutics (@SangamoTx) / X

Committed to translating our ground-breaking science into genomic medicines that transform patients' lives.

Our Work | Sangamo Therapeutics - HDMZ

Learn about the partnership between Sangamo Therapeutics and HDMZ and view our project components.

SGMO: Sangamo Therapeutics Inc - Stock Price, Quote and News

Get Sangamo Therapeutics Inc (SGMO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Sangamo Therapeutics Reports Recent Business Highlights and ...

Sangamo Therapeutics is a genomic medicine company dedicated to translating ground-breaking science into medicines that transform the lives of ...

Sangamo Therapeutics Inc Company Profile - GlobalData

A biotechnology company that focuses on the research, development, and commercialization of engineered DNA-binding protein Zinc Finger Transcription (ZFPs).

Sangamo Therapeutics, Inc. Common Stock (SGMO) - Nasdaq

Discover real-time Sangamo Therapeutics, Inc. Common Stock (SGMO) stock prices, quotes, historical data, news, and Insights for informed trading and ...

Sangamo Therapeutics Inc. Stock Quote (U.S. - SGMO - MarketWatch

SGMO | Complete Sangamo Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

SANGAMO THERAPEUTICS AND PFIZER ANNOUNCE ...

Under the terms of the collaboration agreement, Sangamo will receive a $70 million upfront payment from Pfizer. Sangamo will be responsible for ...

Sangamo BioSciences - AnnualReports.com

Sangamo Biosciences, Inc. engages in the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene ...

Sangamo Therapeutics - Crunchbase Company Profile & Funding

Sangamo Therapeutics is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives.

Sangamo Therapeutics Reports on Pfizer's Announcement of ...

Giroctocogene fitelparvovec is a novel, investigational gene therapy that contains a bio-engineered AAV6 capsid and a modified B-domain deleted human ...

Sangamo Therapeutics Inc. | Institution outputs | Nature Index

Benefitting from advanced imaging and modelling techniques and genetic tools that enable targeted research, neuroscience has undergone remarkable progress in ...

SGMO | Sangamo Therapeutics Inc. Stock Overview (U.S.: Nasdaq)

Complete Sangamo Therapeutics Inc. stock information by Barron's. View real-time SGMO stock price and news, along with industry-best analysis.